-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62

Benzinga·10/13/2026 21:00:03
UBS analyst Michael Goldsmith maintains American Healthcare REIT (NYSE:AHR) with a Buy and lowers the price target from $63 to $62.